GlassScriptPhysician profile
Youssef Khalafallah
NPI 1881273712
$5,501.43
in general payments reported to CMS, 2019-2025
10 companies · $3,757 in 2025
The $3,757 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $83.72 · 2023: $597 · 2024: $1,064 · 2025: $3,757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,864 · Travel and Lodging: $1,554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,863.94 |
| Travel and Lodging | $1,553.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,248.29 | 2025 | Comprehensive Shoulder System |
| Axogen | $1,174.73 | 2025 | |
| Stryker Corporation | $648.37 | 2022-2024 | Mako, Gamma, Everest Spinal System |
| Vericel Corporation | $527.44 | 2022-2025 | Maci |
| Globus Medical, INC. | $454.34 | 2024 | Excelsiusgps Robotic Navigation System, A/R Femoral Nail, Distal Radius II |
| Medinc of Texas | $258.89 | 2025 | |
| Depuy Synthes Sales INC. | $112.56 | 2024-2025 | Na, Va-Lcp |
| Ethicon US, LLC | $34.77 | 2024 | N/A |
| Bioventus LLC | $28.35 | 2024 | Durolane |
| Convatec INC. | $13.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Youssef Khalafallah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.